Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ralf Linker

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Neurodegenerative Disease Management|November 17, 2017
What's new in multiple sclerosis spasticity research? Poster session highlightsRalf Linker
Neurodegenerative Disease Management|November 17, 2017
ForewordRalf Linker
Der Nervenarzt|June 9, 2023
[Ways to treatment of neuromuscular diseases in neuropediatrics and adult neurology]Ulrike Schara-Schmidt, Ralf Linker
Critical Reviews in Immunology|April 8, 2009
Function of neurotrophic factors beyond the nervous system: inflammation and autoimmune demyelinationRalf Linker, Ralf Gold, Fred Luhder
Journal of Neuroimmunology|January 10, 2019
Immune cell derived BDNF does not mediate neuroprotection of the murine anti-CD52 antibody in a chronic autoimmune mouse modelSeray Demir, Kalliopi Pitarokoili, Ralf Linker, et al.
Neurology|October 24, 2018
Teaching Video NeuroImages: Facial myokymia and myorhythmia in anti-IgLON5 disease: The bitten lipElena Vetter, David G Olmes, Ralf Linker, et al.
Experimental & Translational Stroke Medicine|April 2, 2010
Report on the 1st scientific meeting of the "Verein zur Förderung des Wissenschaftlichen Nachwuchses in der Neurologie" (NEUROWIND e.V.) held in Mittenwalde/Motzen, Germany, Oct. 30th - Nov. 1st, 2009Tim Magnus, Ralf Linker, Sven G Meuth, et al.
Neurodegenerative Disease Management|November 17, 2017
Break-out session highlightsKjell-Morten Myhr, Mathias Mäurer, Marisa Martínez Ginés, et al.
Journal of the Neurological Sciences|June 12, 2025
Ocrelizumab as first-line therapy in highly active relapsing-remitting multiple sclerosisTamar Kvartskhava, David Freudenstein, Nicolas Sarmiento, et al.
Journal of Neurology|August 24, 2007
Rescue therapy with anti-CD20 treatment in neuroimmunologic breakthrough diseaseAndrew Chan, De-Hyung Lee, Ralf Linker, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Neurodegenerative Disease Management|November 17, 2017
What's new in multiple sclerosis spasticity research? Poster session highlightsRalf Linker
Neurodegenerative Disease Management|November 17, 2017
ForewordRalf Linker
Der Nervenarzt|June 9, 2023
[Ways to treatment of neuromuscular diseases in neuropediatrics and adult neurology]Ulrike Schara-Schmidt, Ralf Linker
Critical Reviews in Immunology|April 8, 2009
Function of neurotrophic factors beyond the nervous system: inflammation and autoimmune demyelinationRalf Linker, Ralf Gold, Fred Luhder
Journal of Neuroimmunology|January 10, 2019
Immune cell derived BDNF does not mediate neuroprotection of the murine anti-CD52 antibody in a chronic autoimmune mouse modelSeray Demir, Kalliopi Pitarokoili, Ralf Linker, et al.
Neurology|October 24, 2018
Teaching Video NeuroImages: Facial myokymia and myorhythmia in anti-IgLON5 disease: The bitten lipElena Vetter, David G Olmes, Ralf Linker, et al.
Experimental & Translational Stroke Medicine|April 2, 2010
Report on the 1st scientific meeting of the "Verein zur Förderung des Wissenschaftlichen Nachwuchses in der Neurologie" (NEUROWIND e.V.) held in Mittenwalde/Motzen, Germany, Oct. 30th - Nov. 1st, 2009Tim Magnus, Ralf Linker, Sven G Meuth, et al.
Neurodegenerative Disease Management|November 17, 2017
Break-out session highlightsKjell-Morten Myhr, Mathias Mäurer, Marisa Martínez Ginés, et al.
Journal of the Neurological Sciences|June 12, 2025
Ocrelizumab as first-line therapy in highly active relapsing-remitting multiple sclerosisTamar Kvartskhava, David Freudenstein, Nicolas Sarmiento, et al.
Journal of Neurology|August 24, 2007
Rescue therapy with anti-CD20 treatment in neuroimmunologic breakthrough diseaseAndrew Chan, De-Hyung Lee, Ralf Linker, et al.
Pageof 5